297 related articles for article (PubMed ID: 29256907)
1. Prevalence and drug treatment practices of inflammatory bowel diseases in Poland in the years 2012-2014: an analysis of nationwide databases.
Holko P; Kawalec P; Stawowczyk E
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):456-464. PubMed ID: 29256907
[TBL] [Abstract][Full Text] [Related]
2. Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database.
Kurti Z; Vegh Z; Golovics PA; Fadgyas-Freyler P; Gecse KB; Gonczi L; Gimesi-Orszagh J; Lovasz BD; Lakatos PL
Dig Liver Dis; 2016 Nov; 48(11):1302-1307. PubMed ID: 27481587
[TBL] [Abstract][Full Text] [Related]
3. Market share and costs of biologic therapies for inflammatory bowel disease in the USA.
Yu H; MacIsaac D; Wong JJ; Sellers ZM; Wren AA; Bensen R; Kin C; Park KT
Aliment Pharmacol Ther; 2018 Feb; 47(3):364-370. PubMed ID: 29164650
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
[TBL] [Abstract][Full Text] [Related]
5. Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases.
Han M; Jung YS; Cheon JH; Park S
J Gastroenterol Hepatol; 2019 Jul; 34(7):1166-1174. PubMed ID: 30672608
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
7. Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort.
Vegh Z; Burisch J; Pedersen N; Kaimakliotis I; Duricova D; Bortlik M; Vinding KK; Avnstrøm S; Olsen J; Nielsen KR; Katsanos KH; Tsianos EV; Lakatos L; Schwartz D; Odes S; D'Incà R; Beltrami M; Kiudelis G; Kupcinskap L; Jucov A; Turcan S; Barros LF; Magro F; Lazar D; Goldis A; de Castro L; Hernandez V; Niewiadomski O; Bell S; Langholz E; Munkholm P; Lakatos PL;
J Crohns Colitis; 2015 Sep; 9(9):747-53. PubMed ID: 26055976
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and phenotype in Brazilian patients with inflammatory bowel disease.
Lima Martins A; Volpato RA; Zago-Gomes MDP
BMC Gastroenterol; 2018 Jun; 18(1):87. PubMed ID: 29914399
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study.
Zissimopoulos A; Vradelis S; Konialis M; Chadolias D; Bampali A; Constantinidis T; Efremidou E; Kouklakis G
Scand J Gastroenterol; 2014 Aug; 49(8):942-9. PubMed ID: 24897131
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study.
Ludvigsson JF; Büsch K; Olén O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
BMC Gastroenterol; 2017 Jan; 17(1):23. PubMed ID: 28143594
[TBL] [Abstract][Full Text] [Related]
11. Rising hospitalization rates for inflammatory bowel disease in Poland.
Jakubowski A; Zagórowicz E; Kraszewska E; Bartnik W
Pol Arch Med Wewn; 2014; 124(4):180-90. PubMed ID: 24727650
[TBL] [Abstract][Full Text] [Related]
12. Treatment patterns for biologics in ulcerative colitis and Crohn's disease: a Danish Nationwide Register Study from 2003 to 2015.
Alulis S; Vadstrup K; Borsi A; Nielsen A; Rikke Jørgensen T; Qvist N; Munkholm P
Scand J Gastroenterol; 2020 Mar; 55(3):265-271. PubMed ID: 32116064
[No Abstract] [Full Text] [Related]
13. The Continental Divide: Anti-TNF Use in Pediatric IBD Is Different in North America Compared to Other Parts of the World.
Church PC; Hyams J; Ruemmele F; de Ridder L; Turner D; Griffiths AM
Can J Gastroenterol Hepatol; 2018; 2018():3190548. PubMed ID: 30009157
[TBL] [Abstract][Full Text] [Related]
14. Biological treatment approach to inflammatory bowel disease is similar in academic and nonacademic centres - prime time for decentralisation of inflammatory bowel disease care?
Tepeš K; Hanžel J; Štubljar D; Strmšek K; Erjavec L; Supovec E; Jagodic Z; Končan M; Grosek J; Košir JA; Tomažič A; Kogovšek U; Norčič G; Šibli R; Žnidaršič M; Pačnik Vižintin T; Sodin B; Breznik J; Hribar VA; Ocepek A; Pernat Drobež C; Bukovnik N; Zafošnik A; Marušič T; Jurečič Brglez N; Denkovski M; Smrekar N; Novak G; Koželj M; Kurent T; Simonič J; Pintar Š; Štabuc B; Drobne D
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):728-734. PubMed ID: 38625825
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of inflammatory bowel disease in young Greek Army male recruits from 2006 to 2018: a 13-year retrospective study from a tertiary center.
Kyriakos N; Papaefthymiou A; Giakoumis M; Galanopoulos M; Galanis P; Mylonas I; Karatzas P; Mantzaris G; Liatsos C
Eur J Gastroenterol Hepatol; 2022 Feb; 34(2):153-160. PubMed ID: 33653987
[TBL] [Abstract][Full Text] [Related]
16. Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.
Cars T; Wettermark B; Löfberg R; Eriksson I; Sundström J; Lördal M
J Crohns Colitis; 2016 May; 10(5):556-65. PubMed ID: 26733406
[TBL] [Abstract][Full Text] [Related]
17. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.
Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H
Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423
[TBL] [Abstract][Full Text] [Related]
18. Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease.
Larsen MD; Qvist N; Nielsen J; Kjeldsen J; Nielsen RG; Nørgård BM
J Crohns Colitis; 2016 Jun; 10(6):650-6. PubMed ID: 26802081
[TBL] [Abstract][Full Text] [Related]
19. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study.
Gearry RB; Richardson A; Frampton CM; Collett JA; Burt MJ; Chapman BA; Barclay ML
Inflamm Bowel Dis; 2006 Oct; 12(10):936-43. PubMed ID: 17012964
[TBL] [Abstract][Full Text] [Related]
20. Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN.
Aloi M; Birimberg-Schwartz L; Buderus S; Hojsak I; Fell JM; Bronsky J; Veereman G; Koletzko S; Shaoul R; Miele E; Turner D; Russell RK
Inflamm Bowel Dis; 2016 Jun; 22(6):1378-83. PubMed ID: 27135479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
